FRC consulting on changes to the Corporate Governance Code
The Financial Reporting Council (FRC) is consulting on changes to the UK Corporate Governance Code, which sets out good practice for UK listed companies. This consultation forms part of the FRC’s regular two-yearly review of the Code (used to identify and implement any necessary changes) and follows on from the consultations held in October and November last year.
The consultation covers directors’ remuneration, risk management and going concern, audit committees and audit tendering, and location of the corporate governance disclosures.
Some of the main changes proposed in relation to ‘risk management and going concern’ include requiring companies to state…
Click on the link below to read the rest of the Wragge Lawrence Graham & Co briefing.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Wragge Lawrence Graham & Co
News from The Lawyer
Briefings from Wragge Lawrence Graham & Co
Wragge Lawrence Graham & Co’s finance litigation experts bring you the latest on the cases and issues affecting the lending industry.
Eli Lilly succeeds in overturning award of DNIs regarding UK, FR, IT and ES designations of its European patent
The Court of Appeal has delivered its long-awaited judgment in the Actavis v Eli Lillydispute, ruling that Actavis is not entitled to a declaration of noninfringement (DNI) of Eli Lilly’s European patent.